Desert Medical Advances

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Lupus (SLE)3 trials
• Rheumatoid arthritis3 trials

Phase

• Phase 24 trials
• Phase 42 trials

Status

• Completed5 trials
• Terminated1 trial

Lead sponsor

• Eli Lilly and Company3 trials
• Janssen Research & Development, LLC1 trial
• Lakefront Biotherapeutics NV1 trial
• XBiotech, Inc.1 trial

Closed trials

• Completed

  Natrunix or Placebo in Combination With Methotrexate in Rheumatoid Arthritis

  NCT05363891· Phase 2· XBiotech, Inc.· Source

• Completed

  A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus

  NCT05856448· Phase 2· Lakefront Biotherapeutics NV· Source

• Terminated

  A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus

  NCT05123586· Phase 2· Eli Lilly and Company· Source

• Completed

  A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus

  NCT04882878· Phase 2· Janssen Research & Development, LLC· Source

• Completed

  A Study of Baricitinib in Participants With Rheumatoid Arthritis

  NCT04086745· Phase 4· Eli Lilly and Company· Source

• Completed

  A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

  NCT03915964· Phase 4· Eli Lilly and Company· Source